Collaborative and Seamless Care in Oncology : a Study in Primary Care to Measure and Reinforce Safety and Adherence to Oral Cancer Treatment
Sponsor study identifier
observational
43
1 country
1
Study Start
July 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2011
Actual (reported)Study Completion
September 2014
Actual (reported)The purpose of this study is to implement a support interdisciplinary program(oncologists, pharmacists, physicians, nurses, leagues against cancer) of medication adherence to oral oncology treatments. The aim is to ensure continuity of care between professionals,effectiveness of treatment and patient safety.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2014
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2010
Date type not reportedThis date has not been verified as actual or estimated.
June 3, 2011
Actual (reported)June 10, 2011
Actual (reported)December 2011
Actual (reported)September 2014
Actual (reported)Change in Medication adherence
MEMS data, completed by informations given in motivational interviewing
3 months, 6 months, 9 months, 12 months
Program implementation
1 year
Oncologists, nurses, pharmacists and patients satisfaction
1 year
Effect of Adverse Drug Reaction (ADR) on medication adherence
Adults (18 years old or more) with one of the following oral oncology treatments: letrozole, exémestane, imatinib, sunitinib, nilotinib, evérolimus, déférasirox
Patient with cancer treated by oral medication in swiss-romande hospitals and private oncologists, and enrolled in the adherence program in one of the thirty studies pharmacies.
Policlinique Médicale Universitaire and Centre pluridisciplinaire d'oncologie, CHUV
Lausanne, Canton of Vaud, 1010, Switzerland
Bugnon Olivier, Professor
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Lüthi François, Dr
Clinique Bois-Cerf, Lausanne
Schneider Marie-Paule, PhD
Policlinique Medicale Universitaire
Chevaux Bernard, Dr
Centre Hospitalier Universitaire Vaudois
43 participants (actual enrollment reported by the registry).
First Submitted
June 3, 2011
First Posted
June 10, 2011
Study Start
July 2010
Date type not reportedThis date has not been verified as actual or estimated.
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
1 year
Change in Adverse Drug Reaction (ADR)
3 months, 6 months, 9 months, 12 months
Contact the study team to confirm eligibility.
Troxler Stéphanie, PhD Student
Policlinique Medicale Universitaire
Leila Achtari, MD
Centre Hospitalier Univeristaire Vaudois
Primary Completion
December 2011
Actual (reported)Study Completion
September 2014
Actual (reported)Last Updated
July 17, 2026
Record last verified: 2026-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: